Available Full-Text Publications

291 items found

Abi-Dargham A;Rodenhiser J;Printz D;Zea-Ponce Y;Gil R;Kegeles LS;Weiss R;Cooper TB;Mann JJ;Van Heertum RL;Gorman JM;Laruelle M;  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  2000;97(14):8104-8109      

Alexopoulos GS;Kiosses DN;Choi SJ;Murphy CF;Lim KO;  Frontal white matter microstructure and treatment response of late-life depression: a preliminary study.  American Journal of Psychiatry.  2002;159(11):1929-1932      

Andorfer C;Acker CM;Kress Y;Hof PR;Duff K;Davies P;  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.  Journal of Neuroscience.  2005;25(22):5446-5454      

Arancio O;Antonova I;Gambaryan S;Lohmann SM;Wood JS;Lawrence DS;Hawkins RD;  Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation.  Journal of Neuroscience.  2001;21(1):143-149      

Arancio O;Zhang HP;Chen X;Lin C;Trinchese F;Puzzo D;Liu S;Hegde A;Yan SF;Stern A;Luddy JS;Lue LF;Walker DG;Roher A;Buttini M;Mucke L;Li W;Schmidt AM;Kindy M;Hyslop PA;Stern DM;Du Yan SS;  RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.  EMBO Journal.  2004;23(20):4096-4105      

Ardekani BA;Bappal A;D'angelo D;Ashtari M;Lencz T;Szeszko PR;Butler PD;Javitt DC;Lim KO;Hrabe J;Nierenberg J;Branch CA;Hoptman MJ;  Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia.  Neuroreport.  2005;16(13):1455-1459      

Ardekani BA;Guckemus S;Bachman A;Hoptman MJ;Wojtaszek M;Nierenberg J;  Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.  Journal of Neuroscience Methods.  2005;142(1):67-76      

Bai Y;Markham K;Chen F;Weerasekera R;Watts J;Horne P;Wakutani Y;Mathews PM;Fraser PE;Westaway D;St George-Hyslop P;Schmitt-Ulms G;  The in vivo brain interactome of the amyloid precursor protein.  Molecular & Cellular Proteomics.  2008;7(1):15-34      

Bartlett EJ;Brodie JD;Simkowitz P;Schlosser R;Dewey SL;Lindenmayer JP;Rusinek H;Wolkin A;Cancro R;Schiffer W;  Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.  American Journal of Psychiatry.  1998;155(3):337-343      

Bartus RT;Emerich D;Snodgrass-Belt P;Fu K;Salzberg-Brenhouse H;Lafreniere D;Novak L;Lo ES;Cooper T;Basile AS;  A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.  Journal of Pharmacology & Experimental Therapeutics.  2004;310(2):828-835      

Basavarajappa BS;  Critical enzymes involved in endocannabinoid metabolism.  Protein & Peptide Letters.  2007;14(3):237-246      

Basavarajappa BS;  Neuropharmacology of the endocannabinoid signaling system: molecular mechanisms, biological actions and synaptic plasticity.  Current Neuropharmacology.  2007;5(2):81-97      

Basavarajappa BS;  The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.  Mini-Reviews in Medicinal Chemistry.  2007;7(8):769-779      

Basavarajappa BS;Hungund BL;  Role of the endocannabinoid system in the development of tolerance to alcohol.  Alcohol and Alcoholism.  2005;40(1):15-24      

Bilder RM;  Neurocognitive impairment in schizophrenia and how it affects treatment options. [Review].  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  1997;42(3):255-264      

Bilder RM;Goldman RS;Robinson D;Reiter G;Bell L;Bates JA;Pappadopulos E;Willson DF;Alvir JMJ;Woerner MG;Geisler S;Kane JM;Lieberman JA;  Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates.  American Journal of Psychiatry.  2000;157(4):549-559      

Bilder RM;Goldman RS;Volavka J;Czobor P;Hoptman M;Sheitman B;Lindenmayer JP;Citrome L;McEvoy J;Kunz M;Chakos M;Cooper TB;Horowitz TL;Lieberman JA;  Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder [Comment in: Am J Psychiatry. 2002 Dec;159(12):2118; author reply 2118-9].  American Journal of Psychiatry.  2002;159(6):1018-1028      

Bonanomi D;Menegon A;Miccio A;Ferrari G;Corradi A;Kao HT;Benfenati F;Valtorta F;  Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons.  Journal of Neuroscience.  2005;25(32):7299-7308      

Boroojerdi B;Bushara KO;Corwell B;Immisch I;Battaglia F;Muellbacher W;Cohen LG;  Enhanced excitability of the human visual cortex induced by short-term light deprivation.  Cerebral Cortex.  2000;10(5):529-534      

Bourgeois M;Swendsen J;Young F;Amador X;Pini S;Cassano GB;Lindenmayer JP;Hsu C;Alphs L;Meltzer HY;The InterSePT Study Group;  Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.  American Journal of Psychiatry.  2004;161(8):1494-1496      

Burns M;Gaynor K;Olm V;Mercken M;LaFrancois J;Wang L;Mathews PM;Noble W;Matsuoka Y;Duff K;  Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo.  Journal of Neuroscience.  2003;23(13):5645-5649      

Butler PD;Hoptman MJ;Nierenberg J;Foxe JJ;Javitt DC;Lim KO;  Visual white matter integrity in schizophrenia.  American Journal of Psychiatry.  2006;163(11):2011-2013      

Butler PD;Javitt DC;  Early-stage visual processing deficits in schizophrenia.  Current Opinion in Psychiatry.  2005;18(2):151-157      

Butler PD;Schechter I;Zemon V;Schwartz SG;Greenstein VC;Gordon J;Schroeder CE;Javitt DC;  Dysfunction of early-stage visual processing in schizophrenia [Comment in: Am J Psychiatry. 2002 Apr;159(4):678; author reply 678-9].  American Journal of Psychiatry.  2001;158(7):1126-1133      

Butler PD;Zemon V;Schechter I;Saperstein AM;Hoptman MJ;Lim KO;Revheim N;Silipo G;Javitt DC;  Early-stage visual processing and cortical amplification deficits in schizophrenia.  Archives of General Psychiatry.  2005;62(5):495-504      

Calingasan NY;Park LC;Calo LL;Trifiletti RR;Gandy SE;Gibson GE;  Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.  American Journal of Pathology.  1998;153(2):599-610      

Cancro R;  Book review: The Prehistory of the Mind: The Cognitive Origins of Art, Religion and Science.  American Journal of Psychiatry.  1998;155(12):1797      

Cancro R;  Book review: Delayed Posttraumatic Stress Disorders From Infancy: The Two Trauma Mechanism.  American Journal of Psychiatry.  1998;155(5):701-702      

Cancro R;  Book review: Neurology for Non-Neurologists, 3rd ed..  American Journal of Psychiatry.  1998;155(4):569-570      

Cancro R;  Book review: Cambridge Handbook of Psychology, Health and Medicine.  American Journal of Psychiatry.  1999;156(7):1112      

Cancro R;  The introduction of neuroleptics: A psychiatric revolution.  Psychiatric Services.  2000;51(3):333-335      

Cancro R;  Book review: Psychiatric Drugs.  American Journal of Psychiatry.  2001;158(2):331      

Cancro R;  Book review: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care.  American Journal of Psychiatry.  2001;158(2):331      

Cancro R;  Book review: Drug Effects on Psychomotor Performance.  American Journal of Psychiatry.  2002;159(1):168      

Cancro R;  Book review: Ethics, Culture, and Psychiatry: International Perspectives.  American Journal of Psychiatry.  2003;160(9):1712      

Cancro R;  Book review: The Difficult-to-Treat Psychiatric Patient.  American Journal of Psychiatry.  2003;160(1):201      

Capell A;Grunberg J;Pesold B;Diehlmann A;Citron M;Nixon R;Beyreuther K;Selkoe DJ;Haass C;  The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.  Journal of Biological Chemistry.  1998;273(6):3205-3211      

Cataldo AM;Barnett JL;Pieroni C;Nixon RA;  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.  Journal of Neuroscience.  1997;17(16):6142-6151      

Cataldo AM;Petanceska S;Peterhoff CM;Terio NB;Epstein CJ;Villar A;Carlson EJ;Staufenbiel M;Nixon RA;  App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.  Journal of Neuroscience.  2003;23(17):6788-6792      

Cataldo AM;Peterhoff CM;Troncosco JC;GomezIsla T;Hyman BT;Nixon RA;  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations.  American Journal of Pathology.  2000;157(1):277-286      

Che S;Ginsberg SD;  Amplification of RNA transcripts using terminal continuation.  Laboratory Investigation.  2004;84(1):131-137      

Chen F;Yang DS;Petanceska S;Yang A;Tandon A;Yu G;Rozmahel R;Ghiso J;Nishimura M;Zhang DM;Kawarai T;Levesque G;Mills J;Levesque L;Song YQ;Rogaeva E;Westaway D;Mount H;Gandy S;George-Hyslop P;Fraser PE;  Carboxyl-terminal fragments of Alzheimer beta -amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells.  Journal of Biological Chemistry.  2000;275(47):36794-36802      

Chen PX;Mathews PM;Good PJ;Rossier BC;Geering K;  Unusual degradation of alpha-beta complexes in Xenopus oocytes by beta-subunits of Xenopus gastric H-K-ATPase.  American Journal of Physiology.  1998;275(1 Pt 1):C139-C145      

Cheney DL;Uzunov D;Costa E;Guidotti A;  Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats.  Journal of Neuroscience.  1995;15(6):4641-4650      

Chishti MA;Yang DS;Janus C;Phinney AL;Horne P;Pearson J;Strome R;Zuker N;Loukides J;French J;Turner S;Lozza G;Grilli M;Kunicki S;Morissette C;Paquette J;Gervais F;Bergeron C;Fraser PE;Carlson GA;George-Hyslop PS;Westaway D;  Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.  Journal of Biological Chemistry.  2001;276(24):21562-21570      

Choi IY;Gruetter R;  Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from d-[1-C]glucose in the rat brain in vivo.  Journal of Neurochemistry.  2004;91(4):778-787      

Choi SI;Vidal R;Frangione B;Levy E;  Axonal transport of British and Danish amyloid peptides via secretory vesicles.  FASEB Journal.  2004;18(2):373-375      

Chou JC;  Review and update of the American Psychiatric Association practice guideline for bipolar disorder.  Primary Psychiatry.  2004;11(9):73-84      

Christensen BK;Bilder RM;  Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology.  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  2000;45(3):247-256      

Citrome L;  Schizophrenia and valproate.  Psychopharmacology Bulletin.  2003;37(Suppl 2):74-88      

Citrome L;  Re: Treatment noncompliance with orally disintegrating olanzapine tablets.  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  2004;49(6):412-413      

Citrome L;  Antihostility effects of adjunctive divalproex [letter].  Psychiatric Services.  2004;55(9):1068-1069      

Citrome L;Casey DE;Daniel DG;Wozniak P;Kochan LD;Tracy KA;  Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.  Psychiatric Services.  2004;55(3):290-294      

Citrome L;Jaffe A;Levine J;Allingham B;  Use of mood stabilizers among patients with schizophrenia, 1994-2001.  Psychiatric Services.  2002;53(10):1212      

Citrome L;Jaffe A;Levine J;Allingham B;Robinson J;  Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.  Psychiatric Services.  2004;55(9):1006-1013      

Citrome L;Levine J;Allingham B;  Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.  Psychiatric Services.  2000;51(5):634-638      

Citrome L;Volavka J;  Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement.  Diabetes Care.  2004;27(8):2087-2088      

Citrome L;Volavka J;Czobor P;Sheitman B;Lindenmayer JP;McEvoy J;Cooper TB;Chakos M;Lieberman JA;  Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.  Psychiatric Services.  2001;52(11):1510-1514      

Citrome LL;  Efficacy should drive atypical antipsychotic treatment [letter].  BMJ.  2003;326(7383):283      

Coccaro EF;Kavoussi RJ;Cooper TB;Hauger RL;  Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.  American Journal of Psychiatry.  1997;154(10):1430-1435      

Coccaro EF;Kavoussi RJ;Hauger RL;Cooper TB;Ferris CF;  Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.  Archives of General Psychiatry.  1998;55(8):708-714      

Convit A;de Leon MJ;Tarshish C;De Santi S;Wells C;George A;Saint Louis LA;Rusinek H;  Hippocampal atrophy as detected by width of the temporal horn is greater in Alzheimer dementia than in nondementing cognitive impairment [comment].  American Journal of Neuroradiology.  1997;18(6):1193-1195      

Convit A;Wolf OT;Tarshish C;de Leon MJ;  Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.  Proceedings of the National Academy of Sciences of the United States of America.  2003;100(4):2019-2022      

Coplan JD;Trost RC;Owens MJ;Cooper TB;Gorman JM;Nemeroff CB;Rosenblum LA;  Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions.  Archives of General Psychiatry.  1998;55(5):473-477      

Counts SE;Perez SE;Ginsberg SD;De Lacalle S;Mufson EJ;  Galanin in Alzheimer disease.  Molecular Interventions.  2003;3(3):137-156      

de Leon MJ;Convit A;Wolf OT;Tarshish CY;DeSanti S;Rusinek H;Tsui W;Kandil E;Scherer AJ;Roche A;Imossi A;Thorn E;Bobinski M;Caraos C;Lesbre P;Schlyer D;Poirier J;Reisberg B;Fowler J;  Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).  Proceedings of the National Academy of Sciences of the United States of America.  2001;98(19):10966-10971      

de Leon MJ;McRae T;Rusinek H;Convit A;De Santi S;Tarshish C;Golomb J;Volkow N;Daisley K;Orentreich N;McEwen B;  Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.  Journal of Clinical Endocrinology & Metabolism.  1997;82(10):3251-3259      

DeLisi LE;  Dr. DeLisi replies.  American Journal of Psychiatry.  2004;161(8):1508-1509      

DeLisi LE;  The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.  Schizophrenia Bulletin.  2008;34(2):312-321      

DeLisi LE;  The Katrina disaster and its lessons.  World Psychiatry.  2006;5(1):3-4      

DeLisi LE;Bertisch HC;Brown K;Majcher M;Bappal A;Szulc KU;Ardekani BA;  A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.  Harm Reduction Journal.  2006;3(1):17      

DeLisi LE;Crow TJ;  Drs. DeLisi and Crow reply.  American Journal of Psychiatry.  2003;160(3):598-599      

DeLisi LE;Maurizio A;Yost M;Papparozzi CF;Fulchino C;Katz CL;Altesman J;Biel M;Lee J;Stevens P;  A survey of New Yorkers after the Sept. 11, 2001, terrorist attacks.  American Journal of Psychiatry.  2003;160(4):780-783      

DeLisi LE;Shaw SH;Crow TJ;Shields G;Smith AB;Larach VW;Wellman N;Loftus J;Nanthakumar B;Razi K;Stewart J;Comazzi M;Vita A;Heffner T;Sherrington R;  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.  American Journal of Psychiatry.  2002;159(5):803-812      

Devanand DP;Marder K;Michaels KS;Sackeim HA;Bell K;Sullivan MA;Cooper TB;Pelton GH;Mayeux R;  A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.  American Journal of Psychiatry.  1998;155(11):1512-1520      

Dias EC;Foxe JJ;Javitt DC;  Changing plans: a high density electrical mapping study of cortical control.  Cerebral Cortex.  2003;13(7):701-715      

Dias EC;Segraves MA;  Muscimol-induced inactivation of monkey frontal eye field: effects on visually and memory-guided saccades.  Journal of Neurophysiology.  1999;81(5):2191-2214      

Dockstader C;Gaetz W;Cheyne D;Wang F;Castellanos FX;Tannock R;  MEG event-related desynchronization and synchronization deficits during basic somatosensory processing in individuals with ADHD.  Behavioral and Brain Functions.  2008;4:8      

Doniger GM;Foxe JJ;Murray MM;Higgins BA;Javitt DC;  Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia.  Archives of General Psychiatry.  2002;59(11):1011-1020      

Doniger GM;Silipo G;Rabinowicz EF;Snodgrass JG;Javitt DC;  Impaired sensory processing as a basis for object-recognition deficits in schizophrenia.  American Journal of Psychiatry.  2001;158(11):1818-1826      

Ehrlich ME;Sommer J;Canas E;Unterwald EM;  Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine.  Journal of Neuroscience.  2002;22(21):9155-9159      

Feng J;Chi P;Blanpied TA;Xu Y;Magarinos AM;Ferreira A;Takahashi RH;Kao HT;McEwen BS;Ryan TA;Augustine GJ;Greengard P;  Regulation of neurotransmitter release by synapsin III.  Journal of Neuroscience.  2002;22(11):4372-4380      

FitzGerald M;Malone KM;Li S;Harrison WM;McBride PA;Endicott J;Cooper T;Mann JJ;  Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.  American Journal of Psychiatry.  1997;154(4):556-558      

Foxe JJ;Wylie GR;Martinez A;Schroeder CE;Javitt DC;Guilfoyle D;Ritter W;Murray MM;  Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study.  Journal of Neurophysiology.  2002;88(1):540-543      

Francks C;DeLisi LE;Fisher SE;Laval SH;Rue JE;Stein JF;Monaco AP;  Confirmatory evidence for linkage of relative hand skill to 2p12-q11.  American Journal of Human Genetics.  2003;72(2):499-502      

Francks C;DeLisi LE;Shaw SH;Fisher SE;Richardson AJ;Stein JF;Monaco AP;  Parent-of-origin effects on handedness and schizophrenia susceptibility on chromosome 2p12-q11.  Human Molecular Genetics.  2003;12(24):3225-3230      

Frangos J;Ritter W;Friedman D;  Brain potentials to sexually suggestive whistles show meaning modulates the mismatch negativity.  Neuroreport.  2005;16(12):1313-1317      

Frederikse PH;Yun E;Kao HT;Zigler JS;Sun Q;Qazi AS;  Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation.  Molecular Vision.  2004;10:794-804      

Fu KM;Johnston TA;Shah AS;Arnold L;Smiley J;Hackett TA;Garraghty PE;Schroeder CE;  Auditory cortical neurons respond to somatosensory stimulation.  Journal of Neuroscience.  2003;23(20):7510-7515      

Fu KM;Shah AS;O' Connell MN;McGinnis T;Eckholdt H;Lakatos P;Smiley J;Schroeder CE;  Timing and laminar profile of eye position effects on auditory responses in primate auditory cortex.  Journal of Neurophysiology.  2004;92(6):3522-3531      

Galanter M;Dermatis H;Egelko S;De Leon G;  Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic.  Psychiatric Services.  1998;49(4):533-535      

Gandy S;Petanceska S;  Authors' reply.  PLoS Medicine.  2005;2(3):e85      

George AE;de Leon MJ;Golomb J;Kluger A;Convit A;  Imaging the brain in dementia: expensive and futile?.  American Journal of Neuroradiology.  1997;18(10):1847-1850      

Ghoshal N;Smiley JF;DeMaggio AJ;Hoekstra MF;Cochran EJ;Binder LI;Kuret J;  A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.  American Journal of Pathology.  1999;155(4):1163-1172      

Ginsberg SD;Che S;  Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus.  Laboratory Investigation.  2004;84(8):952-962      

Gitler D;Xu Y;Kao HT;Lin D;Lim S;Feng J;Greengard P;Augustine GJ;  Molecular determinants of synapsin targeting to presynaptic terminals.  Journal of Neuroscience.  2004;24(14):3711-3720      

Glazer WM;Conley RR;Citrome L;  Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study.  CNS Spectrums.  2006;11(9 (Suppl 10)):1-13      

Gong B;Vitolo OV;Trinchese F;Liu S;Shelanski M;Arancio O;  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.  Journal of Clinical Investigation.  2004;114(11):1624-1634      

Goodman AB;  Three independent lines of evidence suggest retinoids as causal to schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  1998;95(13):7240-7244      

Grbovic OM;Mathews PM;Jiang Y;Schmidt SD;Dinakar R;Summers-Terio NB;Ceresa BP;Nixon RA;Cataldo AM;  Rab5-stimulated up-regulation of the endocytic pathway increases intracellular {beta}-cleaved amyloid precursor protein carboxyl-terminal fragment levels and A{beta} production.  Journal of Biological Chemistry.  2003;278(33):31261-31268      

Greenberg WM;  Book review: The Antidepressant Survival Program: How to Beat the Side Effects and Enhance the Benefits of Your Medication, by Robert Hedaya.  American Journal of Psychiatry.  2002;159(1):167      

Greenberg WM;  Book review: Guidelines for the Systematic Treatment of the Depressed Patient, by Larry Beutler, John Clarkin and Bruce Bongar.  American Journal of Psychiatry.  2002;159(7):1256      

Greenberg WM;  Book review: Descriptions and Prescriptions: Values, Mental Disorders and the DSMs, edited by John Z. Sadler [correction in Am J Psychiatry 160:1537, August 2003].  American Journal of Psychiatry.  2003;160(5):1021-1022      

Greenberg WM;  The Biopsychosocial Approach: Past, Present, Future [book review].  American Journal of Psychiatry.  2005;162(7):1398      

Greenfield JP;Xu HX;Greengard P;Gandy S;Seeger M;  Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein.  Journal of Biological Chemistry.  1999;274(48):33843-33846      

Grover A;Houlden H;Baker M;Adamson J;Lewis J;Prihar G;Pickering-Brown S;Duff K;Hutton M;  5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.  Journal of Biological Chemistry.  1999;274(21):15134-15143      

Guerra CB;Busch R;Doebele RC;Liu W;Sawada T;Kwok WW;Chang MD;Mellins ED;  Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.  Journal of Immunology.  1998;160(9):4289-4297      

Gugino LD;Chabot RJ;Prichep LS;John ER;Formanek V;Aglio LS;  Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane.  British Journal of Anaesthesia.  2001;87(3):421-428      

Harrison G;Hopper K;Craig T;Laska E;Siegel C;Wanderling J;Dube KC;Ganev K;Giel R;an der HW;Holmberg SK;Janca A;Lee PW;Leon CA;Malhotra S;Marsella AJ;Nakane Y;Sartorius N;Shen Y;Skoda C;Thara R;Tsirkin SJ;Varma VK;Walsh D;Wiersma D;  Recovery from psychotic illness: a 15- and 25-year international follow-up study.  British Journal of Psychiatry.  2001;178:506-517      

Hasegawa H;Sanjo N;Chen F;Gu YJ;Shier C;Petit A;Kawarai T;Katayama T;Schmidt S;Mathews P;Ulms G;Fraser PE;St George-Hyslop P;  Both the sequence and length of the C-terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.  Journal of Biological Chemistry.  2004;279(45):46455-46463      

Heijtz RD;Alexeyenko A;Castellanos FX;  Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD.  Behavioral and Brain Functions.  2007;3(1):33      

Helpern JA;  The missing element [editorial].  American Journal of Neuroradiology.  2001;22(7):1235-1236      

Helpern JA;  The promise of high-field-strength MR imaging.  American Journal of Neuroradiology.  2003;24(9):1738-1739      

Hemby SE;Ginsberg SD;Brunk B;Arnold SE;Trojanowski JQ;Eberwine JH;  Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.  Archives of General Psychiatry.  2002;59(7):631-640      

Heresco-Levy U;Ermilov M;Shimoni J;Shapira B;Silipo G;Javitt DC;  Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.  American Journal of Psychiatry.  2002;159(3):480-482      

Heresco-Levy U;Javitt DC;Ermilov M;Mordel C;Silipo G;Lichtenstein M;  Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.  Archives of General Psychiatry.  1999;56(1):29-36      

Hirasawa M;Ohshima T;Takahashi S;Longenecker G;Honjo Y;Veeranna;Pant HC;Mikoshiba K;Brady RO;Kulkarni AB;  Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects.  Proceedings of the National Academy of Sciences of the United States of America.  2004;101(16):6249-6254      

Hopper K;  Returning to the community--again [editorial].  Psychiatric Services.  2002;53(11):1355      

Hopper K;  Rethinking social recovery in schizophrenia: what a capabilities approach might offer.  Social Science & Medicine.  2007;65(5):868-879      

Hopper K;Barrow SM;  Two genealogies of supported housing and their implications for outcome assessment.  Psychiatric Services.  2003;54(1):50-54      

Hoptman MJ;Ardekani BA;Butler PD;Nierenberg J;Javitt DC;Lim KO;  DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis.  Neuroreport.  2004;15(16):2467-2470      

Hoptman MJ;Volavka J;Czobor P;Gerig G;Chakos M;Blocher J;Citrome LL;Sheitman B;Lindenmayer JP;Lieberman JA;Bilder RM;  Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.  Journal of Neuropsychiatry & Clinical Neurosciences.  2006;18(4):509-515      

Hoptman MJ;Volavka J;Weiss EM;Czobor P;Szeszko PR;Gerig G;Chakos M;Blocher J;Citrome LL;Lindenmayer JP;Sheitman B;Lieberman JA;Bilder RM;  Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.  Psychiatry Research.  2005;140(2):133-145      

Hoptman MJ;Yates KF;Patalinjug MB;Wack RC;Convit A;  Clinical prediction of assaultive behavior among male psychiatric patients at a maximum-security forensic facility.  Psychiatric Services.  1999;50(11):1461-1466      

Hrabe J;Hrabetova S;Segeth K;  A model of effective diffusion and tortuosity in the extracellular space of the brain.  Biophysical Journal.  2004;87(3):1606-1617      

Hrabetova S;Hrabe J;Nicholson C;  Dead-space microdomains hinder extracellular diffusion in rat neocortex during ischemia.  Journal of Neuroscience.  2003;23(23):8351-8359      

Hui KS;Saito M;Hui M;  A novel neuron-specific aminopeptidase in rat brain synaptosomes: its identification, purification, and characterization.  Journal of Biological Chemistry.  1998;273(47):31053-31060      

Hungund BL;Basavarajappa BS;  Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.  Alcohol and Alcoholism.  2000;35(2):126-133      

Ivkovic S;Ehrlich ME;  Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro.  Journal of Neuroscience.  1999;19(13):5409-5419      

Javitt DC;  Glutamate involvement in schizophrenia: focus on N-methyl-D-aspartate receptors.  Primary Psychiatry.  2006;13(10):38-46      

Javitt DC;Shelley AM;Silipo G;Lieberman JA;  Deficits in auditory and visual context-dependent processing in schizophrenia - Defining the pattern.  Archives of General Psychiatry.  2000;57(12):1131-1137      

Javitt DC;Steinschneider M;Schroeder CE;Arezzo JC;  Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  1996;93(21):11962-11967      

Jones K;Colson PW;Holter MC;Lin S;Valencia E;Susser E;Wyatt RJ;  Cost-effectiveness of critical time intervention to reduce homelessness among persons with mental illness.  Psychiatric Services.  2003;54(6):884-890      

Kane JM;Eerdekens M;Lindenmayer JP;Keith SJ;Lesem M;Karcher K;  Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.  American Journal of Psychiatry.  2003;160(6):1125-1132      

Kessler RC;Berglund PA;Bruce ML;Koch JR;Laska EM;Leaf PJ;Manderscheid RW;Rosenheck RA;Walters EE;Wang PS;  The prevalence and correlates of untreated serious mental illness.  Health Services Research.  2001;36(6 Pt 1):987-1007      

Kim D;Wylie G;Pasternak R;Butler PD;Javitt DC;  Magnocellular contributions to impaired motion processing in schizophrenia.  Schizophrenia Research.  2006;82(1):1-8      

King SR;Ginsberg SD;Ishii T;Smith RG;Parker KL;Lamb DJ;  The steroidogenic acute regulatory (StAR) protein Is expressed in steroidogenic cells of the day-old (P1) brain.  Endocrinology.  2004;145(10):4775-4780      

King SR;Manna PR;Ishii T;Syapin PJ;Ginsberg SD;Wilson K;Walsh LP;Parker KL;Stocco DM;Smith RG;Lamb DJ;  An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain.  Journal of Neuroscience.  2002;22(24):10613-10620      

Klein RL;Lin WL;Dickson DW;Lewis J;Hutton M;Duff K;Meyer EM;King MA;  Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.  American Journal of Pathology.  2004;164(1):347-353      

Komano H;Seeger M;Gandy S;Wang GT;Krafft GA;Fuller RS;  Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast.  Journal of Biological Chemistry.  1998;273(48):31648-31651      

Kowa H;Sakakura T;Matsuura Y;Wakabayashi T;Mann DM;Duff K;Tsuji S;Hashimoto T;Iwatsubo T;  Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.  American Journal of Pathology.  2004;165(1):273-281      

Krakowski M;  Violent behavior: choosing antipsychotics and other agents.  Current Psychiatry.  2007;6(4):63-70      

Krakowski M;Czobor P;  Gender differences in violent behaviors: relationship to clinical symptoms and psychosocial factors.  American Journal of Psychiatry.  2004;161(3):459-465      

Krakowski MI;Czobor P;  Psychosocial risk factors associated with suicide attempts and violence among psychiatric inpatients.  Psychiatric Services.  2004;55(12):1414-1419      

Krakowski MI;Czobor P;Citrome L;Bark N;Cooper TB;  Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.  Archives of General Psychiatry.  2006;63(6):622-629      

Kunz M;Yates KF;Czobor P;Rabinowitz S;Lindenmayer JP;Volavka J;  Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral program.  Psychiatric Services.  2004;55(6):654-659      

Kurylo DD;Pasternak R;Silipo G;Javitt DC;Butler PD;  Perceptual organization by proximity and similarity in schizophrenia.  Schizophrenia Research.  2007;95(1-3):205-214      

Lachman HM;Nolan KA;Mohr P;Saito T;Volavka J;  Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.  American Journal of Psychiatry.  1998;155(6):835-837      

Lacombe P;Mathews PM;Schmidt SD;Breidert T;Heneka MT;Landreth GE;Feinstein DL;Galea E;  Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.  Journal of Neuroinflammation.  2004;1:11      

Lakatos P;Shah AS;Knuth KH;Ulbert I;Karmos G;Schroeder CE;  An oscillatory hierarchy controlling neuronal excitability and stimulus processing in the auditory cortex.  Journal of Neurophysiology.  2005;94(3):1904-1911      

Laska EM;  The use of capture-recapture methods in public health [editorial].  Bulletin of the World Health Organization.  2002;80(11):845      

Laudon H;Karlstrom H;Mathews PM;Farmery MR;Gandy SE;Lundkvist J;Lendahl U;Naslund J;  Functional domains in presenilin 1: the Tyr-288 residue controls gamma -secretase activity and endoproteolysis.  Journal of Biological Chemistry.  2004;279(23):23925-23932      

Leadbetter RA;Shutty MS;Elkashef AM;Kirch DG;Spraggins T;Cail WS;Wu H;Bilder RM;Lieberman JA;Wyatt RJ;  MRI changes during water loading in patients with polydipsia and intermittent hyponatremia.  American Journal of Psychiatry.  1999;156(6):958-960      

Leavitt VM;Molholm S;Ritter W;Shpaner M;Foxe JJ;  Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.  Journal of Psychiatry & Neuroscience.  2007;32(5):339-353      

Lebon V;Petersen KF;Cline GW;Shen J;Mason GF;Dufour S;Behar KL;Shulman GI;Rothman DL;  Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.  Journal of Neuroscience.  2002;22(5):1523-1531      

Lencz T;Bilder RM;Turkel E;Goldman RS;Robinson D;Kane JM;Lieberman JA;  Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia.  Archives of General Psychiatry.  2003;60(3):238-243      

Levine IS;Moss S;  Mental health resources on the web for families: a quick reference guide.  .  2002;revised 4/02:      

Levine J;Jaffe A;  Antipsychotic medication utilization in a state mental hospital system, 1994-2000.  .  2004;:199-208      

Lewis CM;Levinson DF;Wise LH;DeLisi LE;Straub RE;Hovatta I;Williams NM;Schwab SG;Pulver AE;Faraone SV;Brzustowicz LM;Kaufmann CA;Garver DL;Gurling HM;Lindholm E;Coon H;Moises HW;Byerley W;Shaw SH;Mesen A;Sherrington R;O'Neill FA;Walsh D;Kendler KS;Ekelund J;Paunio T;Lonnqvist J;Peltonen L;O'Donovan MC;Owen MJ;Wildenauer DB;Maier W;Nestadt G;Blouin JL;Antonarakis SE;Mowry BJ;Silverman JM;Crowe RR;Cloninger CR;Tsuang MT;Malaspina D;Harkavy-Friedman JM;Svrakic DM;Bassett AS;Holcomb J;Kalsi G;McQuillin A;Brynjolfson J;Sigmundsson T;Petursson H;Jazin E;Zoega T;Helgason T;  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.  American Journal of Human Genetics.  2003;73(1):34-48      

Li X;Branch CA;Bertisch HC;Brown K;Szulc KU;Ardekani BA;DeLisi LE;  An fMRI study of language processing in people at high genetic risk for schizophrenia.  Schizophrenia Research.  2007;91(1-3):62-72      

Lim KO;Adalsteinsson E;Spielman D;Sullivan EV;Rosenbloom MJ;Pfefferbaum A;  Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.  Archives of General Psychiatry.  1998;55(4):346-352      

Lim KO;Ardekani BA;Nierenberg J;Butler PD;Javitt DC;Hoptman MJ;  Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia.  American Journal of Psychiatry.  2006;163(11):2008-2010      

Lim KO;Hedehus M;Moseley M;deCrespigny A;Sullivan EV;Pfefferbaum A;  Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.  Archives of General Psychiatry.  1999;56(4):367-374      

Lindenmayer JP;Czobor P;Volavka J;Citrome L;Sheitman B;Mcevoy JP;Cooper TB;Chakos M;Lieberman JA;  Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.  American Journal of Psychiatry.  2003;160(2):290-296      

Lindenmayer JP;Patel R;  Olanzapine-induced ketoacidosis with diabetes mellitus.  American Journal of Psychiatry.  1999;156(9):1471      

Lipton FR;Siegel C;Hannigan A;Samuels J;Baker S;  Tenure in supportive housing for homeless persons with severe mental illness.  Psychiatric Services.  2000;51(4):479-486      

Lipton ML;Fu KM;Branch CA;Schroeder CE;  Ipsilateral hand input to area 3b revealed by converging hemodynamic and electrophysiological analyses in macaque monkeys.  Journal of Neuroscience.  2006;26(1):180-185      

Lusskin SI;Cancro R;Chuang L;Jacobson J;  Prolactin elevation with ziprasidone [letter].  American Journal of Psychiatry.  2004;161(10):1925